Jonathan Drachman
2017 - Seattle Genetics
In 2017, Jonathan Drachman earned a total compensation of $3.5M as Chief Medical Officer at Seattle Genetics, a 8% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $268,382 |
|---|---|
| Option Awards | $1,292,916 |
| Salary | $529,846 |
| Stock Awards | $1,376,990 |
| Other | $12,630 |
| Total | $3,480,764 |
Drachman received $1.4M in stock awards, accounting for 40% of the total pay in 2017.
Drachman also received $268.4K in non-equity incentive plan, $1.3M in option awards, $529.8K in salary and $12.6K in other compensation.
Rankings
In 2017, Jonathan Drachman's compensation ranked 3,036th out of 14,666 executives tracked by ExecPay. In other words, Drachman earned more than 79.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,036 out of 14,666 | 79th |
Division Manufacturing | 1,045 out of 5,770 | 82nd |
Major group Chemicals And Allied Products | 281 out of 2,074 | 87th |
Industry group Drugs | 213 out of 1,730 | 88th |
Industry Biological Products, Except Diagnostic Substances | 40 out of 316 | 87th |
Source: SEC filing on April 3, 2018.
Drachman's colleagues
We found seven more compensation records of executives who worked with Jonathan Drachman at Seattle Genetics in 2017.
2017
Clay Siegall
Seattle Genetics
Chief Executive Officer
2017
Eric Dobmeier
Seattle Genetics
Chief Operating Officer
2017
Todd Simpson
Seattle Genetics
Chief Financial Officer
2017
Vaughn Himes
Seattle Genetics
Chief Technical Officer
2017
Jean Liu
Seattle Genetics
General Counsel
2017
Jean Liu
Seattle Genetics
General Counsel
2017
Darren Cline
Seattle Genetics